[HTML][HTML] Bone cancer pain: from model to mechanism to therapy

NM Luger, DB Mach, MA Sevcik, PW Mantyh - Journal of pain and symptom …, 2005 - Elsevier
Pain is the cancer-related event that is most disruptive to the cancer patient's quality of life.
Although bone cancer pain is one of the most severe and common of the chronic pains that …

Markers of bone remodeling in metastatic bone disease

B Fohr, CR Dunstan, MJ Seibel - The Journal of Clinical …, 2003 - academic.oup.com
Many cancers have a strong propensity to spread to bone. The processes involved in cancer
dissemination to bone are complex and variable, and the changes in bone metabolism …

Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur

DB Mach, SD Rogers, MC Sabino, NM Luger… - Neuroscience, 2002 - Elsevier
Although skeletal pain plays a major role in reducing the quality of life in patients suffering
from osteoarthritis, Paget's disease, sickle cell anemia and bone cancer, little is known about …

Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer‐related pain behaviors and neurochemical changes in the central …

MAC Sabino, NM Luger, DB Mach… - … Journal of Cancer, 2003 - Wiley Online Library
Pain is the most common presenting symptom in patients with bone cancer and bone cancer
pain can be both debilitating and difficult to control fully. To begin to understand the …

Clinical use of markers of bone turnover in metastatic bone disease

MJ Seibel - Nature Clinical Practice Oncology, 2005 - nature.com
Bone metastases profoundly perturb normal bone remodeling. Biochemical markers of bone
turnover have been shown to reflect these tumor-induced changes in bone remodeling and …

Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer

KG Halvorson, MA Sevcik, JR Ghilardi… - The Clinical journal …, 2006 - journals.lww.com
More than 1.3 million cases of cancer will be diagnosed in 2006 in the United States alone,
and 90% of patients with advanced cancer will experience significant, life-altering cancer …

Bisphosphonates for malignancy-related bone disease: current status, future developments

JJ Body - Supportive care in cancer, 2006 - Springer
This review relates to the efficacy and safety of bisphosphonates in metastatic bone disease.
It discusses practical recommendations and possible future indications for bisphosphonate …

Dosing regimens and main adverse events of bisphosphonates

JJ Body - Seminars in oncology, 2001 - Elsevier
The bisphosphonates pamidronate and clodronate are most often used in oncology. Newer,
more potent compounds under study are ibandronate and zoledronate. The main route of …

Pathogenesis of bone metastases: role of tumor‐related proteins

TJ Rosol - Journal of Bone and Mineral Research, 2000 - academic.oup.com
INVESTIGATIONS ON the pathogenesis of cancer metastasis to bone have received
increased attention by scientists worldwide. This is good news for patients that suffer from …

Breast adenocarcinoma MCF-7 cell line induces spontaneous osteoclastogenesis via a RANK-ligand-dependent pathway

V Nicolin, R Bortul, R Bareggi, G Baldini, B Martinelli… - Acta histochemica, 2008 - Elsevier
The metastasis of breast cancer to the skeleton is a serious clinical problem resulting in
hypercalcemia, bone fragility and insurmountable pain. The invasion of bony tissue by …